Rochester, NY — A groundbreaking discovery at the University of Rochester has engineered mice to live significantly longer using a gene from the notoriously long-lived naked mole rat, immediately confirming what many already suspected: death, aging, and the pesky concept of 'running out of time' will soon be a luxury only the poor can afford. The study, published this week, showed mice with the rodent's longevity gene experienced extended lifespans, particularly in their advanced years, sending a clear signal to the world's billionaires that their ultimate escape hatch from mortality is officially being retrofitted.
Sources close to various tech moguls and hedge fund managers, speaking on condition of anonymity while reviewing blueprints for private lunar colonies, confirmed an immediate surge in ‘longevity asset acquisition.’ One venture capitalist, who insisted on being referred to only as 'Alpha Prime,' reportedly liquidated several humanitarian aid funds to secure exclusive 'early access' to the still-theoretical human application of the gene. 'Look, someone has to pioneer this,' Alpha Prime told Hambry, via a disembodied AI voice bot. 'It’s about extending the human condition. And by 'human condition,' I mean the conditions under which I, personally, continue to exist indefinitely.'
The scientific community, while celebrating the potential for understanding aging, remains cautious about the ethical implications of a technology almost certainly destined for elite capture. Dr. Aris Thorne, head of the Institute for Aspirational Proximity Studies and lead researcher on a parallel study observing which billionaires get invited to which other billionaires’ immortality cults, expressed guarded optimism. 'The goal is to extend healthy human lifespan for all,' Dr. Thorne stated, adjusting his glasses. 'But let's be realistic. The market will dictate access. And right now, the market is dictating that Jeff Bezos needs to outlive the heat death of the universe more than your grandma needs to see her great-grandkids graduate.'
Critics argue that focusing on extending the lives of the already powerful simply extends their capacity for problematic decision-making and resource consumption. However, spokespersons for several longevity-focused startups, many already valued in the trillions despite having only 'concept art' of their actual products, dismissed these concerns. 'Longer lives for the innovators mean more innovation,' explained 'Eternal Life Solutions Inc.' in a press release composed entirely of stock photos of serene, suspiciously un-aging C-suite executives. 'Think of the dividends for humanity when the same five people are running everything for the next three millennia. Stability. Predictability. No more pesky generational shifts to upset the quarterly earnings call.'
For the rest of us, death remains the only truly affordable and widely accessible long-term plan.
